HomeSTOK • NASDAQ
add
Stoke Therapeutics Inc
Previous close
$11.79
Day range
$11.15 - $11.78
Year range
$3.35 - $17.58
Market cap
600.18M USD
Avg Volume
629.87K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 4.83M | 294.72% |
Operating expense | 34.17M | 11.02% |
Net income | -25.70M | 16.18% |
Net profit margin | -531.88 | -143.05% |
Earnings per share | -0.46 | 33.33% |
EBITDA | -28.79M | 11.81% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 281.98M | 21.83% |
Total assets | 307.76M | 19.79% |
Total liabilities | 65.05M | -2.51% |
Total equity | 242.71M | — |
Shares outstanding | 52.65M | — |
Price to book | 2.54 | — |
Return on assets | -28.60% | — |
Return on capital | -37.12% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -25.70M | 16.18% |
Cash from operations | -17.48M | 19.83% |
Cash from investing | -88.28M | -476.08% |
Cash from financing | 120.65M | 251,254.17% |
Net change in cash | 14.90M | 765.49% |
Free cash flow | -1.79M | 91.93% |
About
Founded
2014
Headquarters
Website
Employees
110